Clinical Trials Browser

Recruiting × Drug-Related Side Effects and Adverse Reactions × Dermatologic × Clear all

NCT05652673 2025-02-28

Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial

Phase NA Recruiting

Melanoma, Drug-Related Side Effects and Adverse Reactions